Header Logo

Connection

Masebole Masenya to Antiretroviral Therapy, Highly Active

Back to Details
This is a "connection" page, showing publications Masebole Masenya has written about Antiretroviral Therapy, Highly Active.
Masebole Masenya
Connection Strength
0,146
Antiretroviral Therapy, Highly Active
  1. Dolutegravir with emtricitabine and tenofovir alafenamide or tenofovir disoproxil fumarate versus efavirenz, emtricitabine, and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection (ADVANCE): week 96 results from a randomised, phase 3, non-inferiority trial. Lancet HIV. 2020 10; 7(10):e666-e676.
    View in: PubMed
    Score: 0,146
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.